Edgar Selzer

Edgar Selzer

UNVERIFIED PROFILE

Are you Edgar Selzer?   Register this Author

Register author
Edgar Selzer

Edgar Selzer

Publications by authors named "Edgar Selzer"

Are you Edgar Selzer?   Register this Author

69Publications

1243Reads

45Profile Views

Quantitative and qualitative analysis of integrin subtype expression in melanocytes and melanoma cells.

J Recept Signal Transduct Res 2020 Feb 17:1-9. Epub 2020 Feb 17.

Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10799893.2020.1727923DOI Listing
February 2020

Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma.

Eur Arch Otorhinolaryngol 2019 May 16;276(5):1487-1492. Epub 2019 Mar 16.

Department of Otorhinolaryngology and Head and Neck Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-019-05381-0DOI Listing
May 2019

PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.

Histopathology 2018 Oct 4;73(4):573-584. Epub 2018 Jul 4.

Department of Otorhinolaryngology, Head and Neck Surgery, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13646DOI Listing
October 2018

Experience in Intra-arterial Chemotherapy using Two Protocols for the Treatment of OSCC over Two Decades at the University Hospital Vienna.

Clinics (Sao Paulo) 2018 10 18;73:e433. Epub 2018 Oct 18.

Department of Cranio, Maxillofacial and Oral Surgery, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6061/clinics/2018/e433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178862PMC
October 2018

Comparative Analysis of Clinical and Pathological Lymph Node Staging Data in Head and Neck Squamous Cell Carcinoma Patients Treated at the General Hospital Vienna.

Radiol Oncol 2018 Jun 11;52(2):173-180. Epub 2018 May 11.

Department of Otorhinolaryngology and Phoniatry, Hospital St. John of God and Vienna Sigmund Freud University (Medical Faculty), Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/raon-2018-0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043886PMC
June 2018

ÖGRO survey on radiotherapy capacity in Austria : Status quo and estimation of future demands.

Strahlenther Onkol 2018 04 8;194(4):284-292. Epub 2017 Dec 8.

Universitätsklinik für Strahlentherapie-Radioonkologie, Comprehensive Cancer Center Graz, Medizinische Universität Graz, Auenbruggerplatz 32, 8036, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-017-1240-8DOI Listing
April 2018

A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria.

Wien Klin Wochenschr 2017 Jun 15;129(11-12):398-403. Epub 2017 Feb 15.

Department of Otorhinolaryngology, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-017-1171-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486734PMC
June 2017

Erratum to "Neoadjuvant radiotherapy plus radical surgery for locally advanced stage III/IV oral cancer: Analysis of prognostic factors affecting overall survival" [Oral Oncol. 60 (2016) 1-7].

Oral Oncol 2016 12 31;63:e8. Epub 2016 Oct 31.

University Clinic of Radiotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2016.10.016DOI Listing
December 2016

Neoadjuvant radiotherapy plus radical surgery for locally advanced stage III/IV oral cancer: Analysis of prognostic factors affecting overall survival.

Oral Oncol 2016 09 28;60:1-7. Epub 2016 Jun 28.

University Clinic of Radiotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2016.06.014DOI Listing
September 2016

Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.

Wien Klin Wochenschr 2016 May 26;128(9-10):320-8. Epub 2016 Feb 26.

Otorhinolaryngology-Head and Neck Surgery, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-016-0963-3DOI Listing
May 2016

Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: Comparative analysis of inflammation-based prognostic scoring systems.

Strahlenther Onkol 2015 Jun 13;191(6):486-94. Epub 2015 Jan 13.

Department of Radiotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-014-0803-1DOI Listing
June 2015

Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells.

Am J Cancer Res 2015 15;5(2):560-74. Epub 2015 Jan 15.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna Waehringer Guertel 18-20, A-1090 Vienna, Austria ; Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396035PMC
May 2015

Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy.

Strahlenther Onkol 2015 Mar 25;191(3):209-16. Epub 2014 Sep 25.

Departments of Otorhinolaryngology: Head and Neck Surgery, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00066-014-0753-7
Publisher Site
http://dx.doi.org/10.1007/s00066-014-0753-7DOI Listing
March 2015

Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.

Strahlenther Onkol 2014 Sep 9;190(9):832-8. Epub 2014 Apr 9.

Department of Otorhinolaryngology-Head and Neck Surgery, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-014-0652-yDOI Listing
September 2014

Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.

Expert Rev Clin Pharmacol 2013 Nov;6(6):663-76

Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2013.841540DOI Listing
November 2013

Postoperative failure of platelet recovery is an independent risk factor for poor survival in patients with oral and oropharyngeal cancer.

Clin Oral Investig 2013 Apr 29;17(3):913-9. Epub 2012 May 29.

Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00784-012-0755-8DOI Listing
April 2013

Survival of patients with pathologic T0N+ oral and oropharyngeal cancer after neoadjuvant therapy and surgery: the minority report.

Oral Surg Oral Med Oral Pathol Oral Radiol 2013 Mar 30;115(3):293-8. Epub 2012 Aug 30.

Department of Cranio-, Maxillofacial, and Oral Surgery, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oooo.2012.03.033DOI Listing
March 2013

The impact of molecular targets in cancer drug development: major hurdles and future strategies.

Expert Rev Clin Pharmacol 2013 Jan;6(1):23-34

Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/ecp.12.71
Publisher Site
http://dx.doi.org/10.1586/ecp.12.71DOI Listing
January 2013

4-({(Z)-5-[(Z)-3-Eth-oxy-4-hy-droxy-benzyl-idene]-3-methyl-4-oxo-1,3-thia-zolidin-2-yl-idene}amino)-benzoic acid dimethyl-formamide monosolvate.

Acta Crystallogr Sect E Struct Rep Online 2012 Dec 24;68(Pt 12):o3417-8. Epub 2012 Nov 24.

Department of Chemistry, University of Natural Resources and Life Sciences, Muthgasse 18, A-1190 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1107/S1600536812047307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589002PMC
December 2012

Impact of elective neck dissection on regional recurrence and survival in cN0 staged oral maxillary squamous cell carcinoma.

Oral Oncol 2012 Feb 4;48(2):173-8. Epub 2011 Oct 4.

University Hospital for Cranio-Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2011.09.006DOI Listing
February 2012

Basic principles of molecular effects of irradiation.

Wien Med Wochenschr 2012 Feb;162(3-4):47-54

Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10354-012-0052-9DOI Listing
February 2012

Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab.

Strahlenther Onkol 2011 Jun 16;187(6):373-7. Epub 2011 May 16.

Department of Radiotherapy, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-011-2217-7DOI Listing
June 2011

Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studies.

PLoS Curr 2011 Mar 16;3:RRN1223. Epub 2011 Mar 16.

Clinic for Internal Medicine & Infectious Diseases, Dept. 4, University of Veterinary Medicine Vienna and Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, Austria;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059814PMC
March 2011

Impact of molecular targets in cancer drug development: historical influence and future perspectives.

Authors:
Edgar Selzer

Expert Rev Clin Pharmacol 2010 Mar;3(2):161-3

Department of Radiation Oncology, General Hospital, Waehringer Guertel 18-20, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ecp.10.8DOI Listing
March 2010

Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines.

Strahlenther Onkol 2010 Mar 22;186(3):143-8. Epub 2010 Feb 22.

Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Währinger Gürtel 18–20, Vienna, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00066-010-2069-6
Publisher Site
http://dx.doi.org/10.1007/s00066-010-2069-6DOI Listing
March 2010

The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells.

Strahlenther Onkol 2009 May 15;185(5):310-7. Epub 2009 May 15.

Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-009-1929-4DOI Listing
May 2009

Targeted therapies in solid tumours: pinpointing the tumour's Achilles heel.

Curr Pharm Des 2009 ;15(2):207-42

Department of Medicine I and Cancer Center, General Hospital-Medical University Vienna, Waehringer Guertel 18-20, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161209787002906DOI Listing
March 2009

[Organ sparing treatment modalities - which type of treatment for which carcinoma?].

Wien Med Wochenschr 2008 ;158(9-10):264-9

Klinische Abteilung für Onkologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10354-008-0531-1DOI Listing
October 2008

Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system.

Neurobiol Dis 2007 Dec 3;28(3):261-75. Epub 2007 Aug 3.

Medical University Vienna, Center for Brain Research, Division of Neuroimmunology, Spitalgasse 4, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2007.05.006DOI Listing
December 2007

Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells.

Cancer Biol Ther 2006 Oct 26;5(10):1348-54. Epub 2006 Oct 26.

Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.5.10.3224DOI Listing
October 2006

Induction of mixed chimerism through transplantation of CD45-congenic mobilized peripheral blood stem cells after nonmyeloablative irradiation.

Biol Blood Marrow Transplant 2006 Mar;12(3):284-92

Division of Transplantation, Department of Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791050081
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2005.11.011DOI Listing
March 2006

Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting.

Int J Radiat Oncol Biol Phys 2006 Feb;64(2):551-61

Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.09.032DOI Listing
February 2006

Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines.

Oncol Rep 2005 Dec;14(6):1523-6

Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
December 2005

Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.

Clin Cancer Res 2005 Dec;11(24 Pt 1):8632-6

Department of Otorhinolaryngology, Head and Neck Surgery, Division of Oncology and Medical Statistics, Center of Excellence for Clinical and Experimental Oncology, University of Vienna Medical School, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1170DOI Listing
December 2005

Combination of betulinic acid with cisplatin--different cytotoxic effects in two head and neck cancer cell lines.

Oncol Rep 2005 Sep;14(3):667-71

Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
September 2005

Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death.

Anticancer Res 2005 Jul-Aug;25(4):2697-703

Department of Radiotherapy and Radiobiology, University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
September 2005

The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade.

Am J Transplant 2005 Jun;5(6):1237-47

Division of Transplantation, Department of Surgery, Vienna General Hospital, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-6143.2005.00862.xDOI Listing
June 2005

Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells.

Head Neck 2003 Sep;25(9):732-40

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hed.10231
Publisher Site
http://dx.doi.org/10.1002/hed.10231DOI Listing
September 2003

Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.

Am J Surg Pathol 2003 Jul;27(7):1013-9

Department of Pathology, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000478-200307000-00019DOI Listing
July 2003

Betulinic acid-induced Mcl-1 expression in human melanoma--mode of action and functional significance.

Mol Med 2002 Dec;8(12):877-84

Department of Clinical Pharmacology, Section of Experimental Oncology and Molecular Pharmacology, University Hospital Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039966PMC
December 2002

Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer.

Int J Cancer 2002 Nov;102(3):237-43

Department of Radiotherapy and Radiobiology, University Hospital Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10708DOI Listing
November 2002

Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival.

Cancer Lett 2002 May;179(2):197-203

Department of Radiotherapy and Radiobiology, University Hospital Vienna, Währinger Gürtel 18-20, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-3835(01)00872-2DOI Listing
May 2002